Veramed, one of the UK’s fastest growing Contract Research Organisations (CRO) providing specialist statistics and programming services to the bio-pharmaceutical industry, has appointed Alexander Schacht as Executive VP of Launch and Commercialisation Data Sciences to spearhead the company’s new Launch and Commercialisation Business unit. Alexander joins Veramed from UCB, where he held a statistical sciences […]

The post Veramed appoints Alexander Schacht to lead new Launch & Commercialisation business unit first appeared on World Pharma Today.